Scientists hunt for early clues to stop dangerous cancer treatment reactions
NCT ID NCT06377059
Summary
This study aims to better predict and detect dangerous side effects, like Cytokine Release Syndrome (CRS), in blood cancer patients receiving new immunotherapies. Researchers will monitor 100 patients using wireless sensors to track vital signs and blood tests to measure immune responses. The goal is to create a model that identifies high-risk patients early, so doctors can intervene sooner and improve safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rigshospitalet
RECRUITINGCopenhagen O, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.